Sort
21,453 grants matching “tuberculosis”
WADA (West Africa Database on Antiretroviral Therapy) Collaboration
$806,578Francois Dabis · University Of Bordeaux Ii · U01 · FY2006 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$806,468John R. Chan · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$806,468John R. Chan · Albert Einstein College Of Medicine · R01 · FY2019 · AI
Development of a New Diamine (SQ109) for the Treatment of C. difficile Infection
$806,416Marina N Protopopova · Sequella, Inc. · R01 · FY2012 · AI
Identifying correlates of risk for future tuberculosis disease progression in children (INTREPID)
$806,256James Alexander Seddon · Stellenbosch University · R01 · FY2024 · AI
Innovative Approaches to Tuberculosis Control
$806,190Richard E Chaisson · Johns Hopkins University · U19 · FY2007 · AI
Simulating Protein Structures, Complexes, And Dynamics
$806,087Peter J Steinbach · Center For Information Technology · ZIA · FY2017 · CT
TB Vaccine Development in Nonhuman Primate Model
$805,810John L Vandeberg · Texas Biomedical Research Institute · R01 · FY2007 · AI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis
$805,741Courtney C Aldrich · University Of Minnesota · R01 · FY2018 · AI
The Role of Lipid-specific T cells in Mediating Protection Against M. tuberculosis
$805,629Chetan Seshadri · University Of Washington · R01 · FY2022 · AI
Hypoxia, tuberculosis, and T cell dysfunction
$805,368Samuel M Behar · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
Development of novel penems for drug-resistant tuberculosis
$804,846Craig A Townsend · Johns Hopkins University · R01 · FY2018 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$804,735Krishna P Reddy · Massachusetts General Hospital · R01 · FY2021 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$804,593Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2024 · AI
Technology Core
$804,529Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2015 · AI
Dual Targeting of Mtb Resistance Mechanisms
$804,168Christoph Grundner · Seattle Children'S Hospital · R01 · FY2021 · AI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY
$803,940Chiyome L Fukino · Hawaii State Department Of Health · U52 · FY2009 · PS
Screening Complete TB Proteome for Protective Antigens
$803,880Alan Greener · Gene Therapy Systems, Inc. · R44 · FY2007 · AI
Molecular Analysis of Host Immune Response in Leprosy
$803,706Robert L Modlin · University Of California Los Angeles · R01 · FY2024 · AI
Molecular Genetic Analysis of Mycobacterium Tuberculosis
$803,583William Robert Jacobs · Albert Einstein College Of Medicine · R37 · FY2023 · AI
Enhancing ATG-dependent Defense Against Pathogens w/Therapeutics Lead CP
$803,574Robert Hilgraf · Washington University · U19 · FY2018 · AI
Task 6: Technical Support for Tuberculosis Therapeutics
$803,239Jon Carl Mirsalis · Sri International · N01 · FY2016 · AI
Rapid Diagnosis of MDR TB from Sputum using a Small Fully Integrated Nucleic Acid
$803,134Angelika Niemz · Keck Graduate Inst Of Applied Life Scis · R01 · FY2013 · AI
Novel Methods to Inform HIV/TB Clinical Trial Development
$803,055Krishna P Reddy · Massachusetts General Hospital · R01 · FY2023 · AI
Longtitudinal Studies of HIV-Associated Bacterial Pneumonia
$803,016William N Rom · New York University School Of Medicine · R01 · FY2008 · HL